Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association ; volume:22 ; number:1 ; day:5 ; month:12 ; year:2024 ; pages:1-6 ; date:12.2024
Thrombosis journal ; 22, Heft 1 (5.12.2024), 1-6, 12.2024
- Creator
-
Li, Ting Hon Stanford
Yip, Pui Lun
Chan, Hui Yiu
Chan, Ho Kin Stephen
Wong, Wai Shan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-024-00680-x
- URN
-
urn:nbn:de:101:1-2502192113301.056425632805
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Ting Hon Stanford
- Yip, Pui Lun
- Chan, Hui Yiu
- Chan, Ho Kin Stephen
- Wong, Wai Shan
- SpringerLink (Online service)
Other Objects (12)
Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome
Trials and tribulations in lupus anticoagulant testing
Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab
The “LUPUS” Anticoagulant: Manifestations and Possible Mechanisms of Action
Mixing studies for lupus anticoagulant: mostly yes, sometimes no
Mixing studies for lupus anticoagulant: mostly no, sometimes yes
Lupus
Lupus
Lupus
Lupu
Lupus
Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome
Trials and tribulations in lupus anticoagulant testing
Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab
The “LUPUS” Anticoagulant: Manifestations and Possible Mechanisms of Action
Mixing studies for lupus anticoagulant: mostly yes, sometimes no
Mixing studies for lupus anticoagulant: mostly no, sometimes yes
Lupus
Lupus
Lupus
Lupu
Lupus
Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome
Trials and tribulations in lupus anticoagulant testing
Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab
The “LUPUS” Anticoagulant: Manifestations and Possible Mechanisms of Action
Mixing studies for lupus anticoagulant: mostly yes, sometimes no
Mixing studies for lupus anticoagulant: mostly no, sometimes yes
Lupus
Lupus
Lupus
Lupu